Heritable Human Genome Editing? It May Never Be Safe
By Katie Hasson,
Impact Ethics
| 12. 04. 2020
The “CRISPR babies” announced in headlines around the world recently turned two years old, and we still know nothing about their health or wellbeing. Debates continue about whether the societal risks of heritable genome editing are too great to proceed, as do calls for broadly inclusive public participation in such deliberations. In the meantime, we’ve been learning a lot about what can go wrong when using CRISPR to edit human embryos.
In October, the journal Cell published an article describing significant damage to human embryos edited with CRISPR. The experiments conducted in Dieter Egli’s lab at Columbia University found unintended rearrangements or deletions of large stretches of DNA at and around the targeted site. In some cases, the deletions were so large that an entire chromosome was lost. As one headline plainly put it: “In Embryos, Crispr Can Cut Out Whole Chromosomes—That’s Bad”.
The Cell article is the published version of a pre-print paper that, along with two others from Kathy Niakan’s and Shoukrat Mitalipov’s labs, received significant attention in June. At that time, Heidi Ledford...
Related Articles
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...